Small remnants of the right valve of the sinus venosus are commonly found in adults, but the incidence and risk associated with these embryonic remnants in neonates are not well studied. The following report describes a cyanotic neonate with a large Eustachian valve remnant creating a functional cor triatriatum dexter who was initially diagnosed with persistent pulmonary hypertension of the newborn. The cyanosis in this infant improved over the first postnatal week with conservative management, but she suffered multifocal subcortical stroke, likely related to her intracardiac shunt. The clinical presentation and questions regarding long-term management of this rare diagnosis are explored.

Keywords:
Neonatal hypoxia, Cor triatriatum dexter, Congenital heart disease, Embryonic remnant, Right valve of the sinus venosus
1.
Lynch JK, Nelson KB: Epidemiology of perinatal stroke. Curr Opin Pediatr 2001;13:499-505.
2.
Czech T, Pardo AC: School-aged outcomes after neonatal arterial ischemic stroke. Pediatr Neurol Briefs 2016;30:16.
3.
Asakai H, Cardamone M, Hutchinson D, Stojanovski B, Galati JC, Cheung MM, et al: Arterial ischemic stroke in children with cardiac disease. Neurology 2015;85:2053-2059.
4.
Schuchlenz HW, Saurer G, Weihs W, Rehak P: Persisting eustachian valve in adults: relation to patent foramen ovale and cerebrovascular events. J Am Soc Echocardiogr 2004;17:231-233.
5.
Rigatelli G, Dell'Avvocata F, Braggion G, Giordan M, Chinaglia M, Cardaioli P: Persistent venous valves correlate with increased shunt and multiple preceding cryptogenic embolic events in patients with patent foramen ovale: an intracardiac echocardiographic study. Catheter Cardiovas Interv 2008;72:973-976.
6.
Vale TA, Newton JD, Orchard E, Bhindi R, Wilson N, Ormerod OJ: Prominence of the Eustachian valve in paradoxical embolism. Eur J Echocardiogr 2011;12:33-36.
7.
Sehra R, Ensing G, Hurwitz R: Persistent eustachian valves in infants: course and management in symptomatic patients. Pediatr Cardiol 1998;19:221-224.
8.
Qureshi AU, Latiff HA, Sivalingam S: Persistent valve of systemic venous sinus: a cause of neonatal cyanosis. Cardiol Young 2014;24:756-759.
9.
Carton AJ, Gonzalez Rocafort A, Rubio D, Garcia-Guereta L: Persistent embryonic right venous valve giving a cor triatriatum dexter appearance in a cyanotic neonate. J Thorac Cardiovasc Surg 2011;142:e147-e148.
10.
Goel SS, Tuzcu EM, Shishehbor MH, de Oliveira EI, Borek PP, Krasuski RA, et al: Morphology of the patent foramen ovale in asymptomatic versus symptomatic (stroke or transient ischemic attack) patients. Am J Cardiol 2009;103:124-129.
11.
Wu LA, Malouf JF, Dearani JA, Hagler DJ, Reeder GS, Petty GW, et al: Patent foramen ovale in cryptogenic stroke: current understanding and management options. Arch Intern Med 2004;164:950-956.
12.
McQuillen PS, Barkovich AJ, Hamrick SE, Perez M, Ward P, Glidden DV, et al: Temporal and anatomic risk profile of brain injury with neonatal repair of congenital heart defects. Stroke 2007;38(2 suppl):736-741.
13.
Mahle WT, Tavani F, Zimmerman RA, Nicolson SC, Galli KK, Gaynor JW, et al: An MRI study of neurological injury before and after congenital heart surgery. Circulation 2002;106(12 suppl 1):I109-I114.
14.
Miller SP, McQuillen PS, Hamrick S, Xu D, Glidden DV, Charlton N, et al: Abnormal brain development in newborns with congenital heart disease. N Engl J Med 2007;357:1928-1938.
© 2018 S. Karger AG, Basel
2018
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.